healthNov 28, 202454:02pending
Andexanet Alfa FDA Committee Meeting Recap
About this episode
Andexanet Alfa FDA Committee Meeting Recap
03:08 – Purpose/Background
13:30 – Thromboembolism
25:45 – Efficacy/Patient-centered outcomes
34:55 – Discussion questions
Advisory Committee Meeting Link: https://www.youtube.com/live/xztpe5-d9eY
PharmacyToDose.Com
@PharmacyToDose
[email protected]
Learn more about your ad choices. Visit megaphone.fm/adchoices
Get every episode summarized
Each time Pharmacy to Dose: The Critical Care Podcast publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Pharmacy to Dose: The Critical Care Podcast
NSU Symposium Critical Care Clinical Pearls
Pharmacy to Dose: The Critical Care Podcast
Feb 17, 20261:13:32pending
RSI Trial Bonus Episode
Pharmacy to Dose: The Critical Care Podcast
Jan 27, 202631:31pending
RSI Trial Deep Dive
Pharmacy to Dose: The Critical Care Podcast
Jan 21, 20261:34:48pending
2025 ACCP Annual Meeting Recap
Pharmacy to Dose: The Critical Care Podcast
Oct 23, 20251:32:27pending